Concentration profiles and safety of topically applied betulinic acid and NVX-207 in eight healthy horses-A randomized, blinded, placebo-controlled, crossover pilot study
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 44 (1) , 47-57
Abstract
The naturally occurring betulinic acid (BA) and its derivative NVX-207 show anticancer effects against equine malignant melanoma (EMM) cells and a potent permeation in isolated equine skin in vitro. The aim of the study was to determine the in vivo concentration profiles of BA and NVX-207 in equine skin and assess the compounds' local and systemic tolerability with the intent of developing a topical therapy against EMM. Eight horses were treated percutaneously in a crossover design with 1% BA, 1% NVX-207 or a placebo in a respective vehicle twice a day for seven consecutive days with a seven-day washout period between each formulation. Horses were treated at the neck and underneath the tail. Concentration profiles of the compounds were assessed by high-performance liquid chromatography in the cervical skin. Clinical and histopathological examinations and blood analyses were performed. Higher concentrations of NVX-207 were found in the skin compared to BA. Good systemic tolerability and only mild local adverse effects were observed in all three groups. This study substantiates the topical application of BA and NVX-207 in further clinical trials with horses suffering from EMM; however, penetration and permeation of the compounds may be altered in skin affected by tumors.Keywords
Funding Information
- Bundesministerium für Wirtschaft und Energie (16KN051526)
This publication has 35 references indexed in Scilit:
- Safety Assessment of 1,2-Glycols as Used in CosmeticsInternational Journal of Toxicology, 2012
- Characterization of NVX‐207, a novel betulinic acid‐derived anti‐cancer compoundEuropean Journal of Clinical Investigation, 2009
- Treatment of actinic keratoses with a novel betulin‐based oleogel. A prospective, randomized, comparative pilot studyJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Betulinic Acid for Cancer Treatment and PreventionInternational Journal of Molecular Sciences, 2008
- Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot studyVeterinary Dermatology, 2006
- Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytesExperimental Dermatology, 2005
- Equine melanoma in a population of 296 grey Lipizzaner horsesEquine Veterinary Journal, 2003
- Equine Melanocytic Tumors: A Retrospective Study of 53 Horses (1988 to 1991)Journal of Veterinary Internal Medicine, 1995
- Prediction of Drug Disposition Kinetics in Skin and Plasma Following Topical AdministrationJournal of Pharmaceutical Sciences, 1984
- THE CONTROL OF EPIDERMAL THICKNESS*British Journal of Dermatology, 1972